Impact of early detection and treatment of diabetes on the 6-year prevalence of cardiac autonomic neuropathy in people with screen-detected diabetes: ADDITION-Denmark, a cluster-randomised study

Prevalence of Neuropathy and Peripheral Arterial Disease and the Impact of Treatment in People With Screen-Detected Type 2 Diabetes: The ADDITION-Denmark study

(2011) M. Charles et al.   DIABETES CARE

Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management

(2011) Vincenza Spallone et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial

(2011) Simon J Griffin et al.   LANCET

Recommendations for the use of cardiovascular tests in diagnosing diabetic autonomic neuropathy☆

(2011) V. Spallone et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Cardiac Autonomic Neuropathy in Diabetes: A clinical perspective

(2010) R. Pop-Busui   DIABETES CARE

Neuropathy: The Crystal Ball for Cardiovascular Disease?

(2010) A. I. Vinik et al.   DIABETES CARE

Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments

(2010) S. Tesfaye et al.   DIABETES CARE

The association between cardiac autonomic neuropathy with metabolic and other factors in subjects with type 1 and type 2 diabetes

(2010) Christina Voulgari et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Elevated Triglycerides Correlate With Progression of Diabetic Neuropathy

(2009) T. D. Wiggin et al.   DIABETES

Cardiac Outcomes After Screening for Asymptomatic Coronary Artery Disease in Patients With Type 2 Diabetes

(2009) Lawrence H. Young et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Stepwise screening for diabetes identifies people with high but modifiable coronary heart disease risk. The ADDITION study

(2008) A. Sandbaek et al.   DIABETOLOGIA